A Reply to comment on "Long-term outcomes of neoadjuvant gefitinib in resectable stage II-IIIA non-small cell lung cancer: A phase II, prospective cohort study". Ma Z, Zhang Y. Lung Cancer 2025;204:108537.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ma Z, Zhang Y. A Reply to comment on "Long-term outcomes of neoadjuvant gefitinib in resectable stage II-IIIA non-small cell lung cancer: A phase II, prospective cohort study". Lung Cancer 2025;204:108537.
PMID: 40473340